Latest Biotech News

The Advanced Research Projects Agency for Health (ARPA-H) unveiled two new multiyear funding programs totaling nine figures: THRIVE, to accelerate development of custom in vivo precision gene...

UCLA researchers identified IGF2BP3 as a master regulator that rewires leukemia cell metabolism and RNA methylation pathways to promote rapid cancer proliferation. This protein enhances glycolytic...

University of Washington researchers developed engineered protein switches that precisely control therapeutic protein activity duration in the body. Unlike traditional affinity modulation, these...

A novel circular RNA (circRNA) therapeutic demonstrated profound efficacy in alleviating osteoarthritis progression in male mice through targeted protein replacement mechanisms. This approach...

Leading oncology centers presented breakthroughs in radiation therapy including targeted radioactive treatments for recurrent prostate and pancreatic cancers, and long-term data confirming...

The U.S. NIH awarded $87 million to establish the Standardized Organoid Modeling Center aiming to develop reproducible protocols for organoid research, elevating its role in drug discovery and...

Crinetics Pharmaceuticals secured FDA approval for Palsonify (paltusotine), the first oral once-daily therapy for adults with acromegaly, an endocrine disorder caused by excess growth hormone....

The U.S. FDA has approved Eli Lilly's imlunestrant (Inluriyo), an oral selective estrogen receptor degrader (SERD), for adults with estrogen receptor-positive, HER2-negative, ESR1-mutant advanced...

President Donald Trump announced a 100% import tariff on branded pharmaceutical drugs starting October 1, with exemptions for companies actively building manufacturing plants in the U.S. This...

Lonza’s Synaffix platform is partnering with Qurient Therapeutics to develop a dual-payload antibody-drug conjugate (ADC) targeting solid tumors. This collaboration combines Synaffix’s...

Researchers are advancing chimeric antigen receptor (CAR) T cell therapies targeting CD70, highly expressed in over 80% of renal cell carcinomas (RCC) but limited in normal tissues. Efforts focus...

Breakthroughs in artificial intelligence are enhancing diagnostics and clinical data interpretation. Ultromics reported improved early detection of cardiac amyloidosis through FDA-cleared AI...

University of Washington researchers introduced engineered protein switches that regulate therapeutic protein activity by controlling binding duration rather than affinity. This innovative...

Leading cancer centers unveiled novel advances in radiation therapy. UCLA researchers highlighted targeted radioactive therapies, innovative stereotactic body radiation techniques (SBRT), and...

Scientists at the Institute of Science Tokyo developed a novel mRNA vaccine demonstrating efficacy in mitigating pathological neovascularization characteristic of age-related macular degeneration...

Crinetics Pharmaceuticals gained FDA approval for Palsonify (paltusotine), the first oral once-daily therapy to treat adult acromegaly patients who are either post-surgery inadequate responders or...

President Donald Trump announced a 100% import tariff on branded pharmaceutical drugs starting October 1, with carve-outs for companies actively constructing manufacturing plants in the U.S. and...

Innovations in bioengineering are reshaping therapeutic delivery and diagnostics. Carnegie Mellon scientists developed biological microscale robots, "AggreBots," from human lung cells capable of...

Cutting-edge studies illuminate new frontiers in oncology. Glycan-dependent T cell recruiting (GlyTR) compounds designed at UC Irvine demonstrate pan-cancer immunotherapy efficacy by selectively...

Recent regulatory advancements fuel treatment options in oncology and rare diseases. Eli Lilly’s oral selective estrogen receptor degrader imlunestrant received FDA approval for late-stage,...